Android app on Google Play

Express Scripts (ESRX) Pricing Aggressively, Leerink Swann Maintains Buy

March 27, 2013 11:57 AM EDT Send to a Friend
Get Alerts ESRX Hot Sheet
Price: $72.29 --0%

Rating Summary:
    13 Buy, 7 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 0
Trade ESRX Now!
Join SI Premium – FREE
Leerink Swann today maintained an Outperform rating on Express Scripts (NASDAQ: ESRX) with a price target of $70 to $75. Analyst David Larsen noted the company was working through some customer service issues, but he still believes the company will beat expectations.

"We believe that Express Scripts is pricing more aggressively than many investors expect, we believe ESRX will benefit from trends in the specialty space by encouraging the use of specialty retail 'lock-out' programs, we estimate that mail is usually the lowest cost channel, and we do not believe that the recently announced Walgreens (NYSE: WAG) and AmerisourceBergen (NYSE: ABC) deal will have a significant negative impact on the PBM space," said Larsen.

For an analyst ratings summary and ratings history on Express Scripts (NASDAQ: ESRX) click here. For more ratings news on Express Scripts click here.

Shares of Express Scripts closed at $58.41 yesterday.




You May Also Be Interested In


Related Categories

Analyst Comments, Analyst EPS View

Add Your Comment